Autoantibodies in alcoholic liver disease

Addiction Biology

Volumn 5, Issue 2, 2000, Pages 141-151

  McFarlane, Ian G ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; AUTOANTIBODY; CYTOKINE; HLA ANTIGEN;

ALCOHOL CONSUMPTION; ALCOHOL LIVER CIRRHOSIS; ALCOHOL LIVER DISEASE; AUTOIMMUNITY; DISEASE PREDISPOSITION; GENETIC POLYMORPHISM; HEPATITIS; HUMAN; IMMUNOPATHOGENESIS; IMMUNOREGULATION; PHENOTYPE; PRIORITY JOURNAL; REVIEW;

EID: 0034052354     PISSN: 13556215     EISSN: None     Source Type: Journal    
DOI: 10.1080/13556210050003720     Document Type: Review

References (115)

1. 1. Saunders JB, Williams R. The genetics of alcoholism: is there an inherited susceptibility to alcohol-related problems? Alcohol Alcohol 1983;18: 189-217.
2. 2. Bondy SC. Ethanol toxicity and oxidative stress. Toxicol Lett 1992;63:231-41.
3. 3. Cederbaum AI. Introduction: role of lipid peroxidation and oxidative stress in alcohol toxicity. Free Radic Biol Med 1989;7:537-9.
4. 4. Zetterman RK. Autoimmuniry and alcoholic liver disease. Am J Med 1990;89:127-8.
5. 5. Crapper RM, Bhathal PS, Mackay IR. Chronic active hepatitis in alcoholic patients. Liver 1983;3: 327-37.
6. 6. Johnson PJ, McFarlane IG. Meeting report: international autoimmune hepatitis group. Hepatology 1993;18:998-1005.
7. 7. Morgan MY, Sherlock S. Sex-related differences among 100 patients with alcoholic liver disease. Br Med J 1977;1:939-41.
8. 8. Saunders JB, Wodak AD, Williams R. What determines susceptibility to liver damage from alcohol? J Roy Soc Med 1984;77:204-16.
9. 9. Thurman RG. Alcoholic liver injury involves activation of Kupffer cells by endotoxin. Am J Physiol 1998;275:G605-11.
10. 10. Helman RA, Temko MH, Nye SW, Fallon HJ. Alcoholic hepatitis. Natural history and evaluation of prednisolone therapy. Ann Intern Med 1971;74:311-21.
11. 11. Imperiale TF, McCullough AJ. Do corticosteroids reduce mortality from alcoholic hepatitis. Ann Intern Med 1990;113:299-307.
12. 12. Ramond MJ, Poynard T, Rueff B et al. A randomized trial of prednisolone in patients with severe alcoholic hepatitis. N Engl J Med 1992; 326:507-12.
13. 13. Bailey RJ, Krasner N, Eddleston AL WF et al. Histocompatibility antigens, autoantibodies, and immunoglobulins in alcoholic liver disease. Br Med J 1976;2:727-9.
14. 14. MacSween RNM. Alcohol and liver injury: genetic and immunologic factors. Acta Med Scand 1976;Suppl. 703:57-65.
15. 15. Morgan MY, Ross MG, Ng CM, Adams DM, Thomas HC, Sherlock S. HLA-B8, immunoglobulins, and antibody responses in alcohol-related liver disease. J Clin Pathol 1980;33:488-92.
16. 16. Zetterman RK, Sorrell MF. Immunologic aspects of alcoholic liver disease. Gastroenterology 1981; 81:616-24.
17. 17. Gluud C, Tage-Jensen U, Bahnsen M, Dietrichson O, Svejgaard A. Autoantibodies, histocompatibiliry antigens and testosterone in males with alcoholic liver disease. Clin Exp Immunol 1981;44: 31-7.
18. 18. Galbraith RM, Eddleston ALWF, Williams R et al. Enhanced antibody responses in active chronic hepatitis: relation to HLA-B8 and HLA-B12 and porto-systemic shunting. Lancet 1976;I:930-4.
19. 19. Van Epps E, Husby G, Williams RC, Strickland RG. Liver disease - a prominent cause of serum IgE elevation. Clin Exp Immunol 1976;23: 444-50.
20. 20. Scott BB, Rajah SM, Losowsky MS. Histocompatibility antigens in chronic liver disease. Gastroenterology 1977;72:122-5.
21. 21. Bell H, Nordhagen R. Association between HLA-Bw40 and alcoholic liver disease with cirrhosis. Br Med J 1978;I:822-3.
22. 22. Gluud C, Aldershvile J, Dietrichson O et al. Human leucocyte antigens in patients with alcoholic liver cirrhosis. Scand J Gastroenterol 1980; 15:337-41.
23. 23. Monteiro E, Alves MP, Santos ML. Histocompatibility antigens: markers of susceptibility to and protection from alcoholic liver disease in a Portuguese population. Hepatology 1988;8:455-8.
24. 24. Drew PA, Clifton PM, La Brooy JT, Sherman DJ. Polyclonal B cell activation in alcoholic patients with no evidence of liver dysfunction. Clin Exp Immunol 1984;57:479-86.
25. 25. Iturriaga H, Pereda T, Estevez A, Ugarte G. Serum immunoglobulin A changes in alcoholic patients. Ann Clin Res 1977;9:39-43.
26. 26. Mikszta JA, Waltenbaugh C, Kim BS. Impaired antigen presentation by splenocytes of ethanol-consuming C57B1/6 mice. Alcohol 1995;12: 265-71.
27. 27. Thestrup-Pedersen K, Ladefoged K, Andersen P. Lymphocyte transformation test with liver-specific protein and phytohaemagglutinin in patients with liver disease. Clin Exp Immunol 1976;24: 1-8.
28. 28. Young GP, Dudley FJ, Van Der Weyden MB. Suppressive effect of alcoholic liver disease on lymphocyte transformation. Gut 1979;20: 833-9.
29. 29. Mills PR, Shenkin A, Anthony RS et al. Assessment of nutritional status and in vivo immune responses in alcoholic liver disease. Am J Clin Nutr 1983;38:849-59.
30. 30. Kawamura Y, Saito S, Tamaki K, Aoyagi T, Yamamoto H. Observations on lymphocyte subsets defined by monoclonal antibodies in alcoholics without hepatic dysfunction. Hepatology 1983;3:1046-9.
31. 31. Perrin D, Bignon JD, Beaujard E, Cheneau ML. Populations of circulating T lymphocytes in patients with alcoholic cirrhosis. Gastroenterol Clin Biol 1984;8:907-10.
32. 32. Pelletier G, Segond P, Attali P, Briantais MJ, Etienne JP. Pheotype study of blood T lymphocytes in alcoholic hepatopathies. Gastroenterol Clin Biol 1984;8:911-14.
33. 33. Couzigou P, Vincendeau P, Fleury B et al. Changes in circulating lymphocyte subsets in alcoholic hepatopathies. Gastroenterol Clin Biol 1984;8:915-19.
34. 34. Watson RR, Jackson JC, Hartmann R, Sampliner R, Mobley D, Eskelson C. Cellular immune functions, endorphins, and alcohol consumption in males. Alcohol Clin Exp Res 1985;9:248-54.
35. 35. Muller C, Wolf H, Gottlicher J, Eibl MM. Helper-inducer and suppressor inducer lymphocyte subsets in alcoholic cirrhosis. Scand J Gastroenterol 1991;26:295-301.
36. 36. Saad AJ, Jerrells TR. Flow cytometric and immunohistochemical evaluation of ethanol-induced changes in splenic and thymic lymphoid cell populations. Alcohol Clin Exp Res 1991;15: 796-803.
37. 37. Waltenbaugh C, Dech LH. T-cell subsets in alcohol-consuming C57B1/6 mice: alteration of copolymer-specific humoral and cell-mediated immune function. Adv Biosci 1993;86:29-40.
38. 38. Hsuing L, Wang J, Waltenbaugh C. Flow cytometric analysis of lymphocyte subsets of mice maintained on an ethanol-containing liquid diet. Alcohol Clin Exp Res 1994;18:12-20.
39. 39. Cook RT, Waldschmidt TJ, Cook BL, LaBrecque DR, McLatchie K. Loss of the CD5+ and CD45RA(hi) B cell subsets in alcoholics. Clin Exp Immunol 1996;103:304-10.
40. 40. Shiratori Y, Takada H, Hikiba Y et al. Production of chemotactic factor, interleukin 8, from hepatocytes exposed to ethanol. Hepatology 1993;18: 1477-82.
41. 41. Hill DB, Marsano LS, McClain CJ. Increased plasma interleukin-8 concentrations in alcoholic hepatitis. Hepatology 1993;18:576-80.
42. 42. Sheron N, Bird G, Koskinas J et al. Circulating and tissue levels of the neutrophil chemotaxin interleukin-8 are elevated in severe acute alcoholic hepatitis, and tissue levels correlate with neutrophil infiltration. Hepatology 1993;18:41-6.
43. 43. McClain CJ, Cohen DA, Dinarello CA et al. Serum interleukin-1 (IL-1) activity in alcoholic hepatitis. Life Sci 1986;39:1479-85.
44. 44. Devière J, Content J, Denys C et al. Excessive in vitro bacterial lipopolysaccharide-induced production of monokines in cirrhosis. Hepatology 1990;11:628-34.
45. 45. Felver ME, Mezey E, McGuire M et al. Plasma tumour necrosis factor alpha predicts decreased long-term survival in severe alcoholic hepatitis. Alcohol Clin Exp Res 1990;14:255-9.
46. 46. Khoruts A, Stahnke L, McClain CJ, Logan G, Allen JI. Circulating tumour necrosis factor, interleukin-1 and interleukin-6 concentrations in chronic alcoholic patients. Hepatology 1991;13: 267-76.
47. 47. Hill DB, Marsano L, Cohen D, Allen J, Shedlofsky S, McClain CJ. Increased plasma interleukin-6 activity in alcoholic hepatitis. J Lab Clin Med 1992;119:547-52.
48. 48. Grove J, Daly AK, Bassendine MF, Day CP. Association of a tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis. Hepatology 1997;26:143-6.
49. 49. Wilson AG, de Vries N, Pociot F et al. An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8 and DR3 alleles. J Exp Med 1993;177:557-60.
50. 50. D'Alfonso S, Richiardi PM. A polymorphic variation in a putative regulation box of the TNFA promoter region. Immunogenetics 1994;39: 150-4.
51. 51. McGuire W, Hill AVS, Allsopp CEM, Greenwood BM, Kwjatkowski D. Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria. Nature 1994;371:508-11.
52. 52. Israel Y, MacDonald A, Niemela O et al. Hypersensitivity to acetaldehyde-protein adducts. Mol Pharmacol 1992;42:711-17.
53. 53. Klassen LW, Xu DS, Tuma DJ. Immune response to acetaldehyde adducts. Prog Clin Biol Res 1990; 325:333-40.
54. 54. Thiele GM, Klassen LW, Miller JA, Hill G, Tuma DJ. Binding of aldehyde-modified proteins to liver endothelial cells changes the adhesion molecule and TNF-α expression J Allergy Clin Immunol 1997;99:S195.
55. 55. Kanagasundaram N, Kakumu S, Chen T, Leevy CM. Alcoholic hyalin antigen (AHAg) and antibody (AHAb) in alcoholic hepatitis. Gastroenterology 1977;73:1368-73.
56. 56. Katsuma Y, Swierenga SHH, Khettry U, Marceau N, French SW. Changes in the cytokeratin intermediate filament cytoskeleton associated with Mallory body formation in mouse and human liver. Hepatology 1987;7:1215-23.
57. 57. Kehl A, Schober A, Junge U, Winckler K. Solid-phase radioimmunoassay for detection of alcoholic hyalin antigen (AHAg) and antibody (anti-AH). Clin Exp Immunol 1981;43:215-21.
58. 58. Cochrane AM, Moussouros A, Portmann B et al. Lymphocyte cytotoxicity for isolated hepatocytes in alcoholic liver disease. Gastroenterology 1977; 72:918-23.
59. 59. Actis G, Mieli-Vergani G, Portmann B et al. Lymphocytotoxicity to autologous hepatocytes in alcoholic liver disease. Liver 1983;3:8-12.
60. 60. McFarlane IG, Wojcicka BM, Zucker GM, Eddleston ALWF, Williams R. Purification and characterization of human liver-specific lipoprotein (LSP). Clin Exp Immunol 1977;27: 381-90.
61. 61. De Kretser TA, McFarlane IG, Eddleston ALWF, Williams R. A species non-specific liver plasma membrane antigen and its involvement in chronic active hepatitis. Biochem J 1980;186:679-85.
62. 62. Jensen DM, Hall C, Majewski T. The plasma membrane origin of liver-specific protein (LSP). Liver 1983;3:213-19.
63. 63. McFarlane IG. Autoimmunity in liver disease. Clin Sci 1984;67:569-78.
64. 64. McFarlane BM. Hepatocellular membrane antigens. In: McFarlane IG, Williams R, editors. Molecular basis of autoimmune hepatitis, pp. 75-104. Austin, TX:R.G. Landes Company;1996.
65. 65. Manns M, Meyer zum Buschenfelde K-H, Hess, G. Autoantibodies against liver-specific membrane lipoprotein in acute and chronic liver diseases; studies on organ-species-and disease-specificity. Gut 1980;21:955-61.
66. 66. Perperas A, Tsantoulas D, Portmann B, Eddleston ALWF, Williams R. Autoimmunity to a liver membrane lipoprotein and liver damage in alcoholic liver disease. Gut 1981;22:149-52.
67. 67. Meliconi R, Perperas A, Jensen D et al. Anti-LSP antibodies in acute liver disease. Gut 1982;23: 603-7.
68. 68. Hopf U, Meyer zum Buschenfelde K-H, Arnold W. Detection of a liver-membrane autoantibody in HBsAg-negative chronic active hepatitis. N Eng J Med 1976;294:578-82.
69. 69. Burt AD, Anthony RS, Hislop WS, Bouchier IAD, MacSween RNM. Liver membrane antibodies in alcoholic liver disease: I. Prevalence and immunoglobulin class. Gut 1982;23:221-5.
70. 70. Kaku I, Isumi N, Hasumura Y, Takeuchi J. Differences of liver membrane antibody frequency in alcoholic liver disease. Detection of IgG and IgA classes using radioimmunoassay. Dig Dis Sci 1988;33:845-50.
71. 71. Numata T, Kato J, Kohgo Y, Katsuki S, Kondo H, Niitsu Y. Autoantibody against a 78 kDa membrane protein of HepG2 cell in the sera of patients with alcoholic liver diseases. J Gastroenterol 1995; 30:751-7.
72. 72. Vergani D, Mieli-Vergani G, Mondelli M, Portmann B, Eddleston ALWF. Immunoglobulin on the surface of isolated hepatocytes is associated with antibody-dependent cell-mediated cytotoxicity and liver damage. Liver 1987;7:307-15.
73. 73. Trevisan A, Cavigli R, Meliconi R et al. Detection of immunoglobulins G and A on the cell membrane of hepatocytes from patients with alcoholic liver disease. J Clin Pathol 1983;36:530-4.
74. 74. Anthony RS, Farquharson M, MacSween RNM. Liver membrane antibodies in alcoholic liver disease. II. Antibodies to ethanol-altered hepatocytes. J Clin Pathol 1983;36:1302-8.
75. 75. Izumi N, Sato C, Hasumura Y, Takeuchi J. Serum antibodies against alcohol-treated rabbit hepatocytes in patients with alcoholic liver disease. Clin Exp Immunol 1985;61:585-92.
76. 76. Crossley IR, Neuberger J, Davis M, Williams R, Eddleston ALWF. Ethanol metabolism in the generation of new antigenic determinants on liver cells. Gut 1986;27:186-9.
77. 77. Izumi N, Sakai Y, Koyama W, Hasumura Y. Clinical significance of serum antibodies against alcohol-altered hepatocyte membrane in alcoholic liver disease. Alcoholism Clin Exp Res 1989;13: 762-5.
78. 78. Takase S, Tsutsumi M, Kawahara H, Takada N, Takada A. The alcohol-altered liver membrane antibody and hepatitis C virus infection in the progression of alcoholic liver disease. Hepatology 1993;17:9-13.
79. 79. McFarlane IG, McFarlane BM, Major G, Williams R. Identification of the hepatic asialoglycoprotein receptor (hepatic lectin) as a component of liver-specific membrane lipoprotein (LSP). Clin Exp Immunol 1984;55:347-54.
80. 80. Poralla T, Treichel U, Löhr H, Fleischer B. The asialoglycoprotein receptor as target structure in autoimmune liver diseases. Semin Liver Dis 1991; 11:215-22.
81. 81. Treichel U, Meyer zum Buschenfelde K-H. The asialoglycoprotein receptor in autoimmune liver disease. In: Krawitt EL, Wiesner RH, Nishioka M, editors. Autoimmune liver diseases, 2nd edn. Amsterdam: Elsevier; 1998, pp. 273-86.
82. 82. McFarlane BM, Sipos J, Gove CD, McFarlane IG, Williams R. Antibodies against the hepatic asialoglycoprotein receptor perfused in situ preferentially attach to periportal liver cells in the rat. Hepatology 1990;11:408-15.
83. 83. Treichel U, Poralla T, Hess G, Manns M, Meyer zum Buschenfelde K-H. Autoantibodies to human asialoglycoprotein receptor in autoimmune-type chronic hepatitis. Hepatology 1990; 11:606-12.
84. 84. Wojcicka-McFarlane BM. Identification and characterization of the hepatic asialoglycoprotein receptor as an autoantigen. PhD Thesis, University of London; 1990; 231-2.
85. 85. Ma Y, Gäken J, McFarlane BM et al. Alcohol dehydrogenase: a target of humoral autoimmune response in liver disease. Gastroenterology 1997; 112:483-92.
86. 86. Jain S, Markham R, Thomas HC, Sherlock S. Double-stranded DNA-binding capacity of serum in acute and chronic liver disease. Clin Exp Immunol 1976;26:35-41.
87. 87. Gluud C, Tage-Jensen U, Rubinstein E, Henriksen JH. Autoantibodies and immunoglobulins in patients with alcoholic cirrhosis. Relation to measurements of hepatic function and hemodynamics. Digestion 1984;30:1-6.
88. 88. Kurki P, Miettinen A, Slaspuro M, Virtanen I, Stenman S. Cytoskeleton antibodies in chronic active hepatitis, primary biliary cirrhosis, and alcoholic liver disease. Hepatology 1983;3: 297-302.
89. 89. Kurki P, Gripenberg M, Teppo AM, Salaspuro M. Profiles of antinuclear antibodies in chronic active hepatitis, primary biliary cirrhosis and alcoholic liver disease. Liver 1984;4:134-8.
90. 90. Kurki P, Virtanen I, Lehto VP, Alfthan O, Salaspuro M. Antibodies to cytokeratin filaments in patients with alcoholic liver disease. Alcohol Clin Exp Res 1984;8:212-15.
91. 91. Cunningham AL, Mackay IR, Frazer IH et al. Antibody to G-actin in different categories of alcoholic liver disease: quantification by an ELISA and significance for alcoholic cirrhosis. Clin Immunol Immunopathol 1985;34:158-64.
92. 92. Laskin CA, Vidins E, Blendis LM, Soloninka CA. Autoantibodies in alcoholic liver disease. Am J Med 1990;89:129-33.
93. 93. Zauli D, Cassani F, Bianchi FB. Cytoskeletal antigens. In: McFarlane IG, Williams R, editors. Molecular basis of autoimmune hepatitis. Austin, TX: R.G. Landes Company; 1996, pp. 45-58.
94. 94. Yadin O, Sarov B, Naggan L, Slor H, Shoenfeld Y. Natural autoantibodies in the serum of healthy women - a five-year follow-up. Clin Exp Immunol 1989;75:402-6.
95. 95. Lewis EJ, Roberts JL. Is autoimmunity a common denominator in immune complex diseases? Lancet 1980;1:178-80.
96. 96. Klein R, Eisenburg J, Weber P, Seibold F, Berg PA. Significance and specificity of antibodies to neutrophils detected by Western blotting for the serological diagnosis of primary sclerosing cholangitis. Hepatology 1991;14:1147-52.
97. 97. Hardarson S, LaBrecque DR, Mitros FA, Neil GA, Goeken JA. Antineutrophil cytoplasmic antibody in inflammatory bowel and hepatobiliary diseases. High prevalence in ulcerative colitis, primary sclerosing cholangitis, and autoimmune hepatitis. Clin Microbiol Immunol 1993;99: 277-81.
98. 98. Seibold F, Weber P, Schoning A, Mork H, Goppel S, Scheurlen M. Neutrophil antibodies (pANCA) in chronic liver disease and inflammatory bowel disease: do they react with different antigens? Eur J Gastroenterol Hepatol 1996;8:1095-100.
99. 99. Lo SK, Fleming KA, Chapman RW. Prevalence of anti-neutrophil antibody in primary sclerosing cholangitis and ulcerative colitis using an alkaline phosphatase technique. Gut 1992;33:1370-5.
100. 100. Wehr H, Rodo M, Lieber CS, Baraona E. Acetaldehyde adducts and autoantibodies against VLDL and LDL in alcoholics. J Lipid Res 1993; 34:1237-44.
101. 101. Wehr H, Milewski B, Pozniak M, Rodo M. Anti-low-density lipoprotein antibodies in alcoholics without and with liver disease and in social drinkers. Alcohol Alcohol 1997;32:43-9.
102. 102. Chedid A, Kurmanadha R, Chadalawada KR et al. Phospholipid antibodies in alcoholic liver disease. Hepatology 1994;20:1465-71.
103. 103. Biron C, Andreani H, Blanc P et al. Prevalence of antiphospholipid antibodies in patients with chronic liver disease related to alcohol or hepatitis C virus: correlation with liver injury. J Lab Clin Med 1998;131:243-50.
104. 104. Sjoberg K, Lindgren S, Eriksson S. Frequent occurrence of non-specific gliadin antibodies in chronic liver disease. Endomysial but not gliadin antibodies predict coeliac disease in patients with chronic liver disease. Scand J Gastroenterol 1997; 32:1162-7.
105. 105. Volta U, De Franceschi L, Molinaro N. Frequency and significance of anti-gliadin and anti-endomysial antibodies in autoimmune hepatitis. Dig Dis Sci 1998;43:2190-5.
106. 106. Nagayama S, Yokio T, Tanaka H, Kawaguchi Y, Shirasaka T, Kamataki T. Occurrence of autoantibody to protein disulfide isomerase in patients with hepatic disorder. J Toxicol Sci 1994;19: 163-9.
107. 107. de Noronha R, Taylor BA, Wild G, Triger DR, Greaves M. Inter-relationships between platelet count, platelet IgG, serum IgG, immune complexes and severity of liver disease. Clin Lab Haematol 1991;13:127-35.
108. 108. Feistauer SM, Penner E, Mayr WR, Panzer S. Target platelet antigens of autoantibodies in patients with primary biliary cirrhosis. Hepatology 1997;25:1343-5.
109. 109. Homann C, Hansen MB, Graudal N et al. Anti-interleukin-6 autoantibodies in plasma are associated with an increased frequency of infections and increased mortality of patients with alcoholic cirrhosis. Scand J Immunol 1996;44: 623-9.
110. 110. Light JM, Irvine KM, Kjerulf L. Estimating genetic and environmental effects of alcohol use and dependence from a national survey: A "quasiadoption study". J Stud Alcohol 1996;57: 507-20.
111. 111. Bierut LJ, Dinwiddie SH, Begleiter H et al. Familial transmission of substance dependence: alcohol, marijuana, cocaine, and habitual smoking: A report from the collaborative study on the genetics of alcoholism. Arch Gen Psychiatry 1998;55:982-8.
112. 112. List S, Gluud C. A meta-analysis of HLA-antigen prevalences in alcoholics and alcoholic liver disease. Alcohol Alcohol 1994;29:757-64.
113. 113. McFarlane IG. Hepatitis C and alcoholic liver disease. Am J Gastroenterol 1993;88:982-8.
114. 114. Cassani F, Cataleta M, Valentini P et al. Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile. Hepatology 1997;26:561-6.
115. 115. Christensen E, Gluud C. Glucocorticoids are ineffective in alcoholic hepatitis: a meta-analysis adjusting for confounding variables. Gut 1995;37: 113-18.